{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:46:42Z","timestamp":1790617602993,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["project MeLiMun"],"award-info":[{"award-number":["project MeLiMun"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The human cutaneous metastatic melanoma is the deadliest skin cancer. Partial, or less frequently complete spontaneous regressions could be observed, mainly mediated by T cells. Nevertheless, the underlying mechanisms are not fully unraveled. We investigated the first events of the immune response related to cancer regression in Melanoma-bearing Libechov Minipigs (MeLiM), a unique swine model of cutaneous melanoma that regresses spontaneously. Using a multiparameter flow cytometry strategy and integrating new clinical and histological criteria of the regression, we show that T cells and B cells are present only in the late stages, arguing against their role in the initial destruction of malignant cells. NK cells infiltrate the tumors before T cells and therefore might be involved in the induction of the regression process. Myeloid cells represent the main immune population within the tumor microenvironment regardless of the regression stage. Among those, MHCII<jats:sup>+<\/jats:sup> CD163<jats:sup>\u2212<\/jats:sup> macrophages that differ phenotypically and functionally compared to other tumor-associated macrophages, increase in number together with the first signs of regression suggesting their crucial contribution to initiating the regression process. Our study supports the importance of macrophage reprogramming in humans to improve current immunotherapy for metastatic melanoma.<\/jats:p>","DOI":"10.1007\/s00262-023-03503-6","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T13:02:23Z","timestamp":1690894943000},"page":"3507-3521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Deciphering the immune reaction leading to spontaneous melanoma regression: initial role of MHCII+ CD163\u2212 macrophages"],"prefix":"10.1007","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2366-9826","authenticated-orcid":false,"given":"Fany","family":"Blanc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6732-3483","authenticated-orcid":false,"given":"Nicolas","family":"Bertho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Piton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Leplat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5206-4597","authenticated-orcid":false,"given":"Giorgia","family":"Egidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4305-3180","authenticated-orcid":false,"given":"Emmanuelle","family":"Bourneuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5407-8979","authenticated-orcid":false,"given":"Silvia","family":"Vincent-Naulleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7268-5905","authenticated-orcid":false,"given":"Armelle","family":"Pr\u00e9vost-Blondel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"key":"3503_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf D, van Akkooi ACJ, Berking C et al (2018) Melanoma. Lancet 392:971\u2013984. https:\/\/doi.org\/10.1016\/S0140-6736(18)31559-9","journal-title":"Lancet"},{"key":"3503_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2559.1992.tb00988.x","volume":"20","author":"K Blessing","year":"1992","unstructured":"Blessing K, Mclaren KM (1992) Histological regression in primary cutaneous melanoma: recognition, prevalence and significance. Histopathology 20:315\u2013322","journal-title":"Histopathology"},{"key":"3503_CR3","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1111\/jdv.13815","volume":"30","author":"S Ribero","year":"2016","unstructured":"Ribero S, Moscarella E, Ferrara G et al (2016) Regression in cutaneous melanoma: a comprehensive review from diagnosis to prognosis. J Eur Acad Dermatol Venereol 30:2030\u20132037. https:\/\/doi.org\/10.1111\/jdv.13815","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3503_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/j.1365-2559.1983.tb02279.x","volume":"7","author":"VJ McGovern","year":"1983","unstructured":"McGovern VJ, Shaw HM, Milton GW (1983) Prognosis in patients with thin malignant melanoma: influence of regression. Histopathology 7:673\u2013680. https:\/\/doi.org\/10.1111\/j.1365-2559.1983.tb02279.x","journal-title":"Histopathology"},{"key":"3503_CR5","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1001\/archderm.1987.01660340088026","volume":"123","author":"SG Ronan","year":"1987","unstructured":"Ronan SG (1987) Thin malignant melanomas with regression and metastases. Arch Dermatol 123:1326. https:\/\/doi.org\/10.1001\/archderm.1987.01660340088026","journal-title":"Arch Dermatol"},{"key":"3503_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1001\/jamadermatol.2015.2235","volume":"151","author":"S Ribero","year":"2015","unstructured":"Ribero S, Gualano MR, Osella-Abate S et al (2015) Association of histologic regression in primary melanoma with sentinel lymph node status: a systematic review and meta-analysis. JAMA Dermatol 151:1301\u20131307. https:\/\/doi.org\/10.1001\/jamadermatol.2015.2235","journal-title":"JAMA Dermatol"},{"key":"3503_CR7","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/bjc.2017.397","volume":"118","author":"D Zugna","year":"2018","unstructured":"Zugna D, Senetta R, Osella-Abate S et al (2018) Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients. Br J Cancer 118:398\u2013404. https:\/\/doi.org\/10.1038\/bjc.2017.397","journal-title":"Br J Cancer"},{"key":"3503_CR8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z (2020) The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol 17:807\u2013821. https:\/\/doi.org\/10.1038\/s41423-020-0488-6","journal-title":"Cell Mol Immunol"},{"key":"3503_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/pcmr.12926","volume":"34","author":"GH Attrill","year":"2021","unstructured":"Attrill GH, Ferguson PM, Palendira U et al (2021) The tumour immune landscape and its implications in cutaneous melanoma. Pigment Cell Melanoma Res 34:529\u2013549. https:\/\/doi.org\/10.1111\/pcmr.12926","journal-title":"Pigment Cell Melanoma Res"},{"key":"3503_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2018.03.053","volume":"80","author":"LJ Gardner","year":"2019","unstructured":"Gardner LJ, Strunck JL, Wu YP, Grossman D (2019) Current controversies in early-stage melanoma: Questions on incidence, screening, and histologic regression. J Am Acad Dermatol 80:1\u201312. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.053","journal-title":"J Am Acad Dermatol"},{"key":"3503_CR11","doi-asserted-by":"publisher","first-page":"453","DOI":"10.17221\/5739-VETMED","volume":"49","author":"V Hruban","year":"2004","unstructured":"Hruban V, Hor\u00e1k V, Fort\u00fdn K et al (2004) Inheritance of malignant melanoma in the MeLiM strain of miniature pigs. Vet Med (Praha) 49:453\u2013459. https:\/\/doi.org\/10.17221\/5739-VETMED","journal-title":"Vet Med (Praha)"},{"key":"3503_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1046\/j.1600-0749.2003.00101.x","volume":"17","author":"S Vincent-Naulleau","year":"2004","unstructured":"Vincent-Naulleau S, Le Chalony C, Leplat J-J et al (2004) Clinical and histopathological characterization of cutaneous melanomas in the melanoblastoma-bearing libechov minipig model. Pigment Cell Res 17:24\u201335. https:\/\/doi.org\/10.1046\/j.1600-0749.2003.00101.x","journal-title":"Pigment Cell Res"},{"key":"3503_CR13","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00251-017-1037-z","volume":"70","author":"F Blanc","year":"2018","unstructured":"Blanc F, Cr\u00e9chet F, Bruneau N et al (2018) Impact of a CD4 gene haplotype on the immune response in minipigs. Immunogenetics 70:209\u2013222. https:\/\/doi.org\/10.1007\/s00251-017-1037-z","journal-title":"Immunogenetics"},{"key":"3503_CR14","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1593\/neo.08344","volume":"10","author":"F Rambow","year":"2008","unstructured":"Rambow F, Piton G, Bouet S et al (2008) Gene expression signature for spontaneous cancer regression in melanoma pigs. Neoplasia 10:714\u2013726. https:\/\/doi.org\/10.1593\/neo.08344","journal-title":"Neoplasia"},{"key":"3503_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2020.00291","volume":"11","author":"F Blanc","year":"2020","unstructured":"Blanc F, Pr\u00e9vost-blondel A, Piton G et al (2020) The Composition of circulating leukocytes varies with age and melanoma onset in the MeLiM pig biomedical model. Front Immunol 11:1\u201314. https:\/\/doi.org\/10.3389\/fimmu.2020.00291","journal-title":"Front Immunol"},{"key":"3503_CR16","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.21873\/anticanres.12767","volume":"38","author":"D Planska","year":"2018","unstructured":"Planska D, Kovalska J, Cizkova J, Horak V (2018) Tissue rebuilding during spontaneous regression of melanoma in the melanoma-bearing libechov minipig. Anticancer Res 38:4629\u20134636. https:\/\/doi.org\/10.21873\/anticanres.12767","journal-title":"Anticancer Res"},{"key":"3503_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.02299","volume":"9","author":"E Bordet","year":"2018","unstructured":"Bordet E, Blanc F, Tiret M et al (2018) Porcine reproductive and respiratory syndrome virus type 1.3 Lena triggers conventional dendritic cells 1 activation and T helper 1 immune response without infecting dendritic cells. Front Immunol 9:1\u201314. https:\/\/doi.org\/10.3389\/fimmu.2018.02299","journal-title":"Front Immunol"},{"key":"3503_CR18","first-page":"67","volume":"44","author":"Nathanson","year":"1976","unstructured":"Nathanson (1976) Spontaneous regression of malignant melanoma: a review of the literature on incidence, clinical features, and possible mechanisms. Natl Cancer Inst Monogr 44:67\u201376","journal-title":"Natl Cancer Inst Monogr"},{"key":"3503_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/labinvest.2017.8","volume":"97","author":"PP Aung","year":"2017","unstructured":"Aung PP, Nagarajan P, Prieto VG (2017) Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance. Lab Investig 97:657\u2013668. https:\/\/doi.org\/10.1038\/labinvest.2017.8","journal-title":"Lab Investig"},{"key":"3503_CR20","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1172\/jci117116","volume":"93","author":"A Mackensen","year":"1994","unstructured":"Mackensen A, Carcelain G, Viel S et al (1994) Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Invest 93:1397\u20131482. https:\/\/doi.org\/10.1172\/jci117116","journal-title":"J Clin Invest"},{"key":"3503_CR21","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.humpath.2011.02.019","volume":"42","author":"K McKay","year":"2011","unstructured":"McKay K, Moore PC, Smoller BR, Hiatt KM (2011) Association between natural killer cells and regression in melanocytic lesions. Hum Pathol 42:1960\u20131964. https:\/\/doi.org\/10.1016\/j.humpath.2011.02.019","journal-title":"Hum Pathol"},{"key":"3503_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.pathol.2019.04.001","volume":"51","author":"S Osella-Abate","year":"2019","unstructured":"Osella-Abate S, Conti L, Annaratone L et al (2019) Phenotypic characterisation of immune cells associated with histological regression in cutaneous melanoma. Pathology 51:487\u2013493. https:\/\/doi.org\/10.1016\/j.pathol.2019.04.001","journal-title":"Pathology"},{"key":"3503_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.smim.2006.03.002","volume":"18","author":"L Moretta","year":"2006","unstructured":"Moretta L, Bottino C, Pende D et al (2006) Surface NK receptors and their ligands on tumor cells. Semin Immunol 18:151\u2013158. https:\/\/doi.org\/10.1016\/j.smim.2006.03.002","journal-title":"Semin Immunol"},{"key":"3503_CR24","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cell.2019.04.041","volume":"177","author":"L Gauthier","year":"2019","unstructured":"Gauthier L, Morel A, Anceriz N et al (2019) Multifunctional natural killer cell engagers targeting NKp46 trigger protective tumor immunity. Cell 177:1701-1713.e16. https:\/\/doi.org\/10.1016\/j.cell.2019.04.041","journal-title":"Cell"},{"key":"3503_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41423-019-0224-2","volume":"16","author":"G Habif","year":"2019","unstructured":"Habif G, Crinier A, Andr\u00e9 P et al (2019) Targeting natural killer cells in solid tumors. Cell Mol Immunol 16:415\u2013422. https:\/\/doi.org\/10.1038\/s41423-019-0224-2","journal-title":"Cell Mol Immunol"},{"key":"3503_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/cmi.2013.10","volume":"10","author":"M Cheng","year":"2013","unstructured":"Cheng M, Chen Y, Xiao W et al (2013) NK cell-based immunotherapy for malignant diseases. Cell Mol Immunol 10:230\u2013252. https:\/\/doi.org\/10.1038\/cmi.2013.10","journal-title":"Cell Mol Immunol"},{"key":"3503_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5416843","author":"M Cioplea","year":"2020","unstructured":"Cioplea M, Nichita L, Georgescu D et al (2020) FOXP3 in melanoma with regression: between tumoral expression and regulatory T cell upregulation. J Immunol Res. https:\/\/doi.org\/10.1155\/2020\/5416843","journal-title":"J Immunol Res"},{"key":"3503_CR28","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.dci.2018.10.001","volume":"92","author":"J Cizkova","year":"2019","unstructured":"Cizkova J, Sinkorova Z, Strnadova K et al (2019) The role of \u03b1\u03b2 T-cells in spontaneous regression of melanoma tumors in swine. Dev Comp Immunol 92:60\u201368. https:\/\/doi.org\/10.1016\/j.dci.2018.10.001","journal-title":"Dev Comp Immunol"},{"key":"3503_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1615\/CritRevImmunol.2019030020","volume":"39","author":"A Prevost-Blondel","year":"2019","unstructured":"Prevost-Blondel A, Richard Y (2019) Interleukin 4\u2013induced gene 1 as an emerging regulator of B-cell biology and its role in cutaneous melanoma. Crit Rev Immunol 39:39\u201357. https:\/\/doi.org\/10.1615\/CritRevImmunol.2019030020","journal-title":"Crit Rev Immunol"},{"key":"3503_CR30","first-page":"997","volume":"56","author":"RI Nedelcu","year":"2015","unstructured":"Nedelcu RI, Ion DA, Holeab CA et al (2015) Dendritic cells in melanoma\u2014immunohistochemical study and research trends. Rom J Morphol Embryol 56:997\u20131002","journal-title":"Rom J Morphol Embryol"},{"key":"3503_CR31","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1158\/0008-5472.CAN-11-3218","volume":"72","author":"G Erdag","year":"2012","unstructured":"Erdag G, Schaefer JT, Smolkin ME et al (2012) Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res 72:1070\u20131080. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3218","journal-title":"Cancer Res"},{"key":"3503_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B (2019) Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol 19:369\u2013382. https:\/\/doi.org\/10.1038\/s41577-019-0127-6","journal-title":"Nat Rev Immunol"},{"key":"3503_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01563","author":"N Bercovici","year":"2019","unstructured":"Bercovici N, Guerin MV, Trautmann A, Donnadieu E (2019) The remarkable plasticity of macrophages: a chance to fight cancer. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.01563","journal-title":"Front Immunol"},{"key":"3503_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.coi.2021.01.001","volume":"69","author":"V Duhan","year":"2021","unstructured":"Duhan V, Smyth MJ (2021) Innate myeloid cells in the tumor microenvironment. Curr Opin Immunol 69:18\u201328. https:\/\/doi.org\/10.1016\/j.coi.2021.01.001","journal-title":"Curr Opin Immunol"},{"key":"3503_CR35","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","volume":"27","author":"B Ruffell","year":"2015","unstructured":"Ruffell B, Coussens LM (2015) Macrophages and therapeutic resistance in cancer. Cancer Cell 27:462\u2013472. https:\/\/doi.org\/10.1016\/j.ccell.2015.02.015","journal-title":"Cancer Cell"},{"key":"3503_CR36","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2022.02.021","volume":"185","author":"R Nalio Ramos","year":"2022","unstructured":"Nalio Ramos R, Missolo-Koussou Y, Gerber-Ferder Y et al (2022) Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer. Cell 185:1189-1207.e25. https:\/\/doi.org\/10.1016\/j.cell.2022.02.021","journal-title":"Cell"},{"key":"3503_CR37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/CMR.0000000000000352","volume":"27","author":"M Falleni","year":"2017","unstructured":"Falleni M, Savi F, Tosi D et al (2017) M1 and M2 macrophages\u2019 clinicopathological significance in cutaneous melanoma. Melanoma Res 27:200\u2013210. https:\/\/doi.org\/10.1097\/CMR.0000000000000352","journal-title":"Melanoma Res"},{"key":"3503_CR38","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41416-020-01037-7","volume":"123","author":"LF Tremble","year":"2020","unstructured":"Tremble LF, McCabe M, Walker SP et al (2020) Differential association of CD68+ and CD163+ macrophages with macrophage enzymes, whole tumour gene expression and overall survival in advanced melanoma. Br J Cancer 123:1553\u20131561. https:\/\/doi.org\/10.1038\/s41416-020-01037-7","journal-title":"Br J Cancer"},{"key":"3503_CR39","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41423-020-00613-4","volume":"18","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Marchesi F, Jaillon S et al (2021) Tumor-associated myeloid cells: diversity and therapeutic targeting. Cell Mol Immunol 18:566\u2013578. https:\/\/doi.org\/10.1038\/s41423-020-00613-4","journal-title":"Cell Mol Immunol"},{"key":"3503_CR40","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1084\/jem.20182124","volume":"216","author":"A Etzerodt","year":"2019","unstructured":"Etzerodt A, Tsalkitzi K, Maniecki M et al (2019) Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression. J Exp Med 216:2394\u20132411. https:\/\/doi.org\/10.1084\/jem.20182124","journal-title":"J Exp Med"},{"key":"3503_CR41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/CMR.0000000000000549","volume":"29","author":"WJ Lee","year":"2019","unstructured":"Lee WJ, Lee MH, Kim HT et al (2019) Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma. Melanoma Res 29:501\u2013509. https:\/\/doi.org\/10.1097\/CMR.0000000000000549","journal-title":"Melanoma Res"},{"key":"3503_CR42","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature21409","volume":"543","author":"JL Guerriero","year":"2017","unstructured":"Guerriero JL, Sotayo A, Ponichtera HE et al (2017) Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages. Nature 543:428\u2013432. https:\/\/doi.org\/10.1038\/nature21409","journal-title":"Nature"},{"key":"3503_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1346765","volume":"6","author":"JM Weiss","year":"2017","unstructured":"Weiss JM, Guerin MV, Regnier F et al (2017) The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression. Oncoimmunology 6:e1346765. https:\/\/doi.org\/10.1080\/2162402X.2017.1346765","journal-title":"Oncoimmunology"},{"key":"3503_CR44","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1158\/1078-0432.CCR-18-3016","volume":"25","author":"M Viitala","year":"2019","unstructured":"Viitala M, Virtakoivu R, Tadayon S et al (2019) Immunotherapeutic blockade of macrophage clever-1 reactivates the CD8+ T-cell response against immunosuppressive tumors. Clin Cancer Res 25:3289\u20133303. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3016","journal-title":"Clin Cancer Res"},{"key":"3503_CR45","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/leu.2008.380","volume":"23","author":"A Carbonnelle-Puscian","year":"2009","unstructured":"Carbonnelle-Puscian A, Copie-Bergman C, Baia M et al (2009) The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophages. Leukemia 23:952\u2013960. https:\/\/doi.org\/10.1038\/leu.2008.380","journal-title":"Leukemia"},{"key":"3503_CR46","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","volume":"54","author":"K Mulder","year":"2021","unstructured":"Mulder K, Patel AA, Kong WT et al (2021) Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity 54:1883-1900.e5. https:\/\/doi.org\/10.1016\/j.immuni.2021.07.007","journal-title":"Immunity"},{"key":"3503_CR47","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1002\/eji.201041119","volume":"41","author":"F Lasoudris","year":"2011","unstructured":"Lasoudris F, Cousin C, Prevost-Blondel A et al (2011) IL4I1: an inhibitor of the CD8+ antitumor T-cell response in vivo. Eur J Immunol 41:1629\u20131638. https:\/\/doi.org\/10.1002\/eji.201041119","journal-title":"Eur J Immunol"},{"key":"3503_CR48","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1278331","volume":"6","author":"L Bod","year":"2017","unstructured":"Bod L, Lengagne R, Wrobel L et al (2017) IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma. Oncoimmunology 6:e1278331. https:\/\/doi.org\/10.1080\/2162402X.2016.1278331","journal-title":"Oncoimmunology"},{"key":"3503_CR49","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.jid.2018.06.178","volume":"138","author":"JP Ramspott","year":"2018","unstructured":"Ramspott JP, Bekkat F, Bod L et al (2018) Emerging role of IL-4\u2013induced gene 1 as a prognostic biomarker affecting the local T-cell response in human cutaneous melanoma. J Invest Dermatol 138:2625\u20132634. https:\/\/doi.org\/10.1016\/j.jid.2018.06.178","journal-title":"J Invest Dermatol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03503-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-023-03503-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-023-03503-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T07:02:24Z","timestamp":1697266944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-023-03503-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,1]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["3503"],"URL":"https:\/\/doi.org\/10.1007\/s00262-023-03503-6","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,1]]},"assertion":[{"value":"9 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal care and use were carried out under licenses issued by the Direction D\u00e9partementale de la Protection des Populations des Yvelines (DDPPY, agreement number C78-719) and experiments were ethically approved by the Committee on the Ethics of Animal Experiments of AgroParisTech and INRAE Jouy-en-Josas (COMETHEA, authorization number 12\/091).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}